AUS
NZ
UK
CA
USA
IND
Healt
Neurizon Therapeutics Market Position and Developments in the Biotechnology Sector
September 02, 2025 09:09 PM AEST| By Team Kalkine MediaHighlights,Neurizon Therapeutics is positioned in the biotechnology sector with evolving market dynamics.,The company has experienced contrasting shifts in performance despite challenges in operational progress.,Its inclusion within a major Australia...
Ramsay Health Care (ASX:RHC) Declares Dividend as Focus Remains on Cash Flow Strength
September 02, 2025 06:13 PM AEST| By Team Kalkine MediaHighlights,Ramsay Health Care (ASX:RHC) declared a dividend, highlighting reliance on steady cash flows,Dividend history shows reductions compared with prior years, limiting long-term growth consistency,Earnings trends remain weak, but forecasts indi...
Ramsay Health Care (ASX:RHC) Declares Dividend as Focus Remains on Cash Flow Strength
September 02, 2025 06:04 PM AEST| By Team Kalkine MediaHighlights,Ramsay Health Care (ASX:RHC) declared a dividend, highlighting reliance on steady cash flows,Dividend history shows reductions compared with prior years, limiting long-term growth consistency,Earnings trends remain weak, but forecasts indi...
Sonic Healthcare (ASX:SHL) Share Price Outlook – What the ASX 200 Investor Should Know
September 02, 2025 06:01 PM AEST| By Team Kalkine MediaExplore Sonic Healthcare (ASX:SHL) share price insights, financial health, and valuation outlook as one of the major players in the ASX 200 healthcare sector.
Healthcare Stumbles While Materials Surge in ASX August Trade
September 02, 2025 03:52 PM AEST| By Team Kalkine MediaHighlights,S&P/ASX 200 posted steady gains through August with resilience across most sectors,Healthcare dragged lower as CSL (ASX:CSL) recorded a historic daily fall,Rare earths explorer Kaili Resources (ASX:KLR) soared, driving momentum in small-ca...
Race Oncology Expands RC220 Trial in Hong Kong with Focus on Advanced Solid Tumours
September 02, 2025 11:01 AM AEST| By Team Kalkine MediaRace Oncology (ASX:RAC) advances its RC220 trial with the first Hong Kong site activation, strengthening its clinical research efforts in advanced solid tumours.
Santos (ASX:STO) takeover sparks ASX 200 volatility amid state scrutiny
September 01, 2025 04:49 PM AEST| By Team Kalkine MediaHighlights,South Australian government to evaluate the Abu Dhabi-led acquisition of Santos,Ministerial approval required for change in controlling interest for licence holders,Share price movement reflects heightened investor attention on Santos' ope...
Is ASX:MX1 financially exposed? Micro-X debt scrutiny raises questions ASX 300
September 01, 2025 04:19 PM AEST| By Team Kalkine MediaHighlights:,Micro-X (ASX:MX1), listed on the,ASX 300,, has taken on debt after previously holding none.,The company’s liabilities exceed its combined short-term cash and receivables.,Revenue contraction and cash outflows mark challenges ahead for the...
How Alterity Therapeutics (ASX:ATH) Is Managing Growth Amid Cash Flow Questions ASX 300
September 01, 2025 04:05 PM AEST| By Team Kalkine MediaHighlights,Alterity Therapeutics (ASX:ATH) operates in the biotechnology sector, currently listed on the,ASX 300,index.,The company has reported a decrease in cash burn over the past year, signaling operational discipline.,Despite being pre-revenue,...
Insider Buying in ReNerve (ASX:RNV) Faces Value Strain Despite Ownership Confidence All Ordinaries
September 01, 2025 03:29 PM AEST| By Team Kalkine MediaHighlights,Insider share purchases in ReNerve have not recovered from their original costs despite recent price movements,The company’s Independent Chairman previously acquired shares at significantly higher levels,ReNerve insiders hold a considerabl...
Is Micro-X (ASX:MX1) Carrying Too Much Financial Strain?
September 01, 2025 02:59 PM AEST| By Team Kalkine MediaMicro-X (ASX:MX1) reported short-term liabilities exceeding cash reserves and receivables Company continues to operate with a net debt balance and negative EBIT performance Revenues have declined while the business faces balance sheet pressures
4D Medical (ASX:4DX) Soars After FDA Nod for Lung Imaging Tool All Ordinaries
September 01, 2025 02:14 PM AEST| By Team Kalkine MediaHighlights,4D Medical secures US FDA clearance for CT-based lung imaging device,The CT:VQ system offers a non-invasive diagnostic approach without contrast agents,Pro Medicus and Lumos Diagnostics also advance healthcare tech initiatives in the US,4D...
Amplia Therapeutics Lists New Securities on ASX ATX Strengthens Biotech Strategy
September 01, 2025 02:13 PM AEST| By Team Kalkine MediaHighlights,Amplia Therapeutics quotes additional fully paid ordinary securities on the ASX,The move is linked to a previously disclosed transaction to support company operations,Amplia focuses on drug development for cancer and fibrotic diseases,Ampl...
4DMedical (ASX:4DX) Wins FDA Clearance for CT:VQ Imaging, Opening New Pathways in Respiratory Care
September 01, 2025 12:09 PM AEST| By Team Kalkine Media4DMedical (ASX:4DX) secures FDA clearance for CT:VQ imaging software, revolutionising lung diagnostics with advanced technology and expanding access across healthcare systems.
Inside Sigma Healthcare’s Ownership Structure Amid Insider Movements ASX 300
August 29, 2025 08:02 PM AEST| By Team Kalkine MediaSigma Healthcare (ASX:SIG) displays significant insider ownership, with key executives holding substantial stakes A small number of shareholders collectively hold a majority interest in the company Despite recent insider sales, Sigma Healthcare...
ASX 200 index Dividend Timing And Coverage Factors For Sonic Healthcare
August 29, 2025 06:16 PM AEST| By Team Kalkine MediaA concise review of Sonic Healthcare Limited (ASX:SHL) evaluates upcoming distribution timing, payout coverage, and operational context within the broader market, focusing on sustainability signals, historical patterns, and sector dynamics
Paragon Care’s (ASX:PGC) Share Valuation Reflects Growth Confidence ASX 300
August 29, 2025 04:13 PM AEST| By Team Kalkine MediaHighlights,Paragon Care (ASX:PGC) shows elevated valuation against broader Australian peers,Earnings trajectory aligns with optimism around future business expansion,Broader ASX 300 market benchmarks provide contrast to sector-specific pricing,Parago...
Australian Clinical Labs (ASX:ACL) Dividend News Lifts Market Attention ASX 300
August 29, 2025 03:52 PM AEST| By Team Kalkine MediaHighlights,Australian Clinical Labs (ASX:ACL) approaches ex-dividend date for upcoming payout,Shareholders must be recorded before the deadline to receive the announced dividend,Payout aligns with previous distributions supported by company earnings...
ASX200 Healthcare Stocks Struggle Amid Reporting Season Swings
August 29, 2025 03:13 PM AEST| By Team Kalkine MediaHighlights,ASX healthcare sector declines amid turbulent reporting season,CSL (ASX:CSL) and Ramsay (ASX:RHC) weigh heavily on sector performance,Sigma (ASX:SIG) gains traction post Chemist Warehouse merger,The,ASX 200,healthcare sector experienced sh...
Why this ASX Share Remains a Strong Focus Among ASX 200 Companies
August 29, 2025 12:08 PM AEST| By Team Kalkine MediaHighlights,CSL (CSL) operates as a global leader in biotechnology.,Healthcare sector provides resilient and consistent revenue streams.,Growing ethical investment trends support long-term appeal.,CSL in the Spotlight,CSL Ltd (ASX:CSL) has long been r...
Advertise your brand on Kalkine Media